Non-Coding RNAs As Sensors of Oxidative Stress in Neurodegenerative Diseases

Overview

Journal Antioxidants (Basel)

Date 2020 Nov 11

PMID 33171576

Citations 12

Authors

Ana Gamez-Valero

Anna Guisado-Corcoll

Marina Herrero-Lorenzo

Maria Solaguren-Beascoa

Eulalia Marti

Affiliations

Soon will be listed here.

Abstract

Oxidative stress (OS) results from an imbalance between the production of reactive oxygen species and the cellular antioxidant capacity. OS plays a central role in neurodegenerative diseases, where the progressive accumulation of reactive oxygen species induces mitochondrial dysfunction, protein aggregation and inflammation. Regulatory non-protein-coding RNAs (ncRNAs) are essential transcriptional and post-transcriptional gene expression controllers, showing a highly regulated expression in space (cell types), time (developmental and ageing processes) and response to specific stimuli. These dynamic changes shape signaling pathways that are critical for the developmental processes of the nervous system and brain cell homeostasis. Diverse classes of ncRNAs have been involved in the cell response to OS and have been targeted in therapeutic designs. The perturbed expression of ncRNAs has been shown in human neurodegenerative diseases, with these changes contributing to pathogenic mechanisms, including OS and associated toxicity. In the present review, we summarize existing literature linking OS, neurodegeneration and ncRNA function. We provide evidences for the central role of OS in age-related neurodegenerative conditions, recapitulating the main types of regulatory ncRNAs with roles in the normal function of the nervous system and summarizing up-to-date information on ncRNA deregulation with a direct impact on OS associated with major neurodegenerative conditions.

Citing Articles

Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology.

Dhariwal R, Jain M, Mir Y, Singh A, Jain B, Kumar P Front Med (Lausanne). 2025; 12:1522223.

PMID: 39963432 PMC: 11831571. DOI: 10.3389/fmed.2025.1522223.

Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers.

Salvat-Rovira N, Vazquez-Oliver A, Rivas-Asensio E, Herrero-Lorenzo M, Gamez-Valero A, Perez-Perez J Int J Mol Sci. 2025; 25(24.

PMID: 39769471 PMC: 11679985. DOI: 10.3390/ijms252413705.

The interplay between epitranscriptomic RNA modifications and neurodegenerative disorders: Mechanistic insights and potential therapeutic strategies.

Hashmi M, Fatima H, Ahmad S, Rehman A, Safdar F Ibrain. 2024; 10(4):395-426.

PMID: 39691424 PMC: 11649393. DOI: 10.1002/ibra.12183.

A review on gut microbiota and miRNA crosstalk: implications for Alzheimer's disease.

Ayyanar M, Vijayan M Geroscience. 2024; 47(1):339-385.

PMID: 39562408 PMC: 11872870. DOI: 10.1007/s11357-024-01432-5.

Identification of key lncRNAs in age-related macular degeneration through integrated bioinformatics and experimental validation.

Ji Y, Zuo C, Liao N, Yao L, Yang R, Chen H Aging (Albany NY). 2024; 16(6):5435-5451.

PMID: 38484366 PMC: 11006464. DOI: 10.18632/aging.205656.

References

Sierksma A, Lu A, Salta E, Vanden Eynden E, Callaerts-Vegh Z, DHooge R . Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Mol Neurodegener. 2018; 13(1):54. PMC: 6186090. DOI: 10.1186/s13024-018-0285-1. View

Greenway M, Andersen P, Russ C, Ennis S, Cashman S, Donaghy C . ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet. 2006; 38(4):411-3. DOI: 10.1038/ng1742. View

Chen Y, Gao C, Sun Q, Pan H, Huang P, Ding J . MicroRNA-4639 Is a Regulator of DJ-1 Expression and a Potential Early Diagnostic Marker for Parkinson's Disease. Front Aging Neurosci. 2017; 9:232. PMC: 5519626. DOI: 10.3389/fnagi.2017.00232. View

Sedelnikova O, Redon C, Dickey J, Nakamura A, Georgakilas A, Bonner W . Role of oxidatively induced DNA lesions in human pathogenesis. Mutat Res. 2010; 704(1-3):152-9. PMC: 3074954. DOI: 10.1016/j.mrrev.2009.12.005. View

Narasimhan M, Patel D, Vedpathak D, Rathinam M, Henderson G, Mahimainathan L . Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS One. 2012; 7(12):e51111. PMC: 3517581. DOI: 10.1371/journal.pone.0051111. View

Zhao X, He X, Han X, Yu Y, Ye F, Chen Y . MicroRNA-mediated control of oligodendrocyte differentiation. Neuron. 2010; 65(5):612-26. PMC: 2855245. DOI: 10.1016/j.neuron.2010.02.018. View

Fiore R, Khudayberdiev S, Christensen M, Siegel G, Flavell S, Kim T . Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J. 2009; 28(6):697-710. PMC: 2647767. DOI: 10.1038/emboj.2009.10. View

Ghafouri-Fard S, Shoorei H, Taheri M . Non-coding RNAs are involved in the response to oxidative stress. Biomed Pharmacother. 2020; 127:110228. DOI: 10.1016/j.biopha.2020.110228. View

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

10.

Byun K, Yoo Y, Son M, Lee J, Jeong G, Park Y . Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacol Ther. 2017; 177:44-55. DOI: 10.1016/j.pharmthera.2017.02.030. View

11.

Akhter R . Circular RNA and Alzheimer's Disease. Adv Exp Med Biol. 2018; 1087:239-243. DOI: 10.1007/978-981-13-1426-1_19. View

12.

Zhao Y, Sun L, Wang R, Hu J, Cui J . The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena. Crit Rev Oncol Hematol. 2018; 131:76-82. DOI: 10.1016/j.critrevonc.2018.08.005. View

13.

Deng H, Chen W, Hong S, Boycott K, Gorrie G, Siddique N . Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011; 477(7363):211-5. PMC: 3169705. DOI: 10.1038/nature10353. View

14.

Wang L, Yang H, Wang Q, Zhang Q, Wang Z, Zhang Q . Paraquat and MPTP induce alteration in the expression profile of long noncoding RNAs in the substantia nigra of mice: Role of the transcription factor Nrf2. Toxicol Lett. 2018; 291:11-28. DOI: 10.1016/j.toxlet.2018.04.002. View

15.

Martinez A, Portero-Otin M, Pamplona R, Ferrer I . Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol. 2009; 20(2):281-97. PMC: 8094880. DOI: 10.1111/j.1750-3639.2009.00326.x. View

16.

Wang G, Huang Y, Wang L, Zhang Y, Xu J, Zhou Y . MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease. Sci Rep. 2016; 6:26697. PMC: 4879631. DOI: 10.1038/srep26697. View

17.

Packer A, Xing Y, Harper S, Jones L, Davidson B . The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci. 2009; 28(53):14341-6. PMC: 3124002. DOI: 10.1523/JNEUROSCI.2390-08.2008. View

18.

Rousseau A, Bertolotti A . Regulation of proteasome assembly and activity in health and disease. Nat Rev Mol Cell Biol. 2018; 19(11):697-712. DOI: 10.1038/s41580-018-0040-z. View

19.

Aschrafi A, Kar A, Natera-Naranjo O, MacGibeny M, Gioio A, Kaplan B . MicroRNA-338 regulates the axonal expression of multiple nuclear-encoded mitochondrial mRNAs encoding subunits of the oxidative phosphorylation machinery. Cell Mol Life Sci. 2012; 69(23):4017-27. PMC: 11114659. DOI: 10.1007/s00018-012-1064-8. View

20.

Paladino S, Conte A, Caggiano R, Pierantoni G, Faraonio R . Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs. Cell Physiol Biochem. 2018; 47(5):1951-1976. DOI: 10.1159/000491465. View